Resistance to immune checkpoint blockade in patients with cSCC Published 2022-06-20 Download video MP4 360p Recommendations 58:49 Curing metastatic solid tumours with immune checkpoint inhibitors by Professor James Larkin 01:16 KEYTRUDA: CURE FOR ADVANCED ENDOMETRIAL CANCER? 02:06 How melanoma 'deceives' the immune system, increasing resistance to immunotherapy 17:40 What happens to lonely people under anesthesia? 00:48 Improving response to immune checkpoint blockade in cSCC 08:49 ASCO 2024 Top 5 Melanoma & Immunotherapy Abstracts with Omid Hamid, MD 04:12 Immunotherapy for Cancer: Pembrolizumab #cancer #immunotherapy #malignancy 2:09:31 Simon Cowell Opens Up About His Heartbreaking Loss & His Regrets About One Direction! 00:57 How pembrolizumab will change the management of advanced lung cancer 13:44 Cervical Stenosis: Traditional Technology vs. Newer Ultrasonic Technology for Spine Surgery 27:35 Clarifying the Confusing Truth About Depression and Borderline Personality Disorder (BPD) 01:42 Phase I trial of OBX-115, an IL2-sparing TIL, in pre-treated metastatic melanoma 1:27:34 #1 Longevity Surgeon: "Scary Thing Trapping You From A Life Of Health & Happiness" | Vivek Murthy 01:33 Dr.Schuchter: How Long Does Immunotherapy Take to Work 01:07 METIS: Tumor Treating Fields (TTFields) in patients with NSCLC and brain metastases 18:40 Matthew Perry's Death From Ketamine Explained (Is It Safe For You?) 14:46 Excess Deaths at Night - Obstructive Sleep Apnea Explained Clearly 01:38 Phase I trial of SX-682, a CXCR1/2 inhibitor, in metastatic melanoma 02:46 Radio-Iodine Treatment: Graves Disease vs Thyroid Cancer. 17:28 Through Thick & Thin Similar videos 03:48 Overcoming resistance to immune checkpoint inhibitors in NSCLC 07:05 Patient Responses to I-O in CSCC 06:55 Practical Implications for I-O in CSCC 02:45 Correlation between cutaneous immune-related adverse events and OS with immune checkpoint inhibitors 01:25 Dr. Paulson Discusses Acquired Resistance to Immunotherapy 01:48 Tissue specificity in immune responses when using checkpoint blockade immunotherapy to treat tumors 1:17:27 MEET THE EXPERTS: Immunotherapy and systemic treatment of CSCC 07:32 Updates on MRx0518 + pembro in patients with resistance to therapy 08:04 MRx0518 + pembro in patients with resistance to therapy 01:46 Predicting response to checkpoint inhibitors and overcoming resistance in lung cancers 02:29 Overcoming resistance to immunotherapy as first-line therapy in gastric cancer 01:52 Mechanisms of resistance to immunotherapy in NHL 20:33 Prof Ian Davis: Cancer - I used to understand it. 02:05 Improving responses to immunotherapy in NSCLC 14:32 Systemic Therapy For Nonmelanoma Skin Cancer and Emerging Research 02:01 Experimental drug offers hope for advanced skin cancer patients 32:50 Visualizing Tumor Immunity and Response 57:36 KCRS22 Session Two: Novel Pathways for Therapeutics Beyond Checkpoint Inhibitors 01:43 Treating tumors with SYNB1891 to overcome anti-PD1 resistance More results